|
Status |
Public on Dec 31, 2022 |
Title |
The impact of G9a-inhibitors in T-cell and Treg differentiation |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
36272457 |
|
Submission date |
Feb 16, 2022 |
Last update date |
Feb 10, 2023 |
Contact name |
Asha Nair |
E-mail(s) |
nair.asha@mayo.edu
|
Organization name |
Mayo Clinic
|
Street address |
200 1ST ST SW
|
City |
Rochester |
ZIP/Postal code |
55901 |
Country |
USA |
|
|
Platforms (2) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
GPL21290 |
Illumina HiSeq 3000 (Homo sapiens) |
|
Samples (16)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE196226 |
The impact of G9a-inhibitors in T-cell and Treg differentiation [RNA-Seq] |
GSE196903 |
The impact of G9a-inhibitors in T-cell and Treg differentiation [ATAC-seq] |
|
Relations |
BioProject |
PRJNA807687 |